Katherine R Calvo Selected Research

Majeed syndrome

1/2021

Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine R Calvo Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 09/2004
10	GATA2 Deficiency 01/2022 - 09/2011
8	Multiple Myeloma 11/2021 - 01/2011
7	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 07/2012
7	Leukemia 01/2022 - 01/2017
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 09/2012
6	Disease Progression 01/2022 - 10/2014
6	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Infections 01/2022 - 10/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2014
5	Cytopenia 01/2022 - 04/2014
5	VEXAS syndrome 01/2022 - 12/2020
5	Monoclonal Gammopathy of Undetermined Significance 01/2020 - 01/2011
3	Bone Marrow Failure Disorders 01/2022 - 01/2018
3	Hairy Cell Leukemia 12/2021 - 12/2013
3	Residual Neoplasm 12/2021 - 12/2013
3	Thrombocytopenia (Thrombopenia) 10/2021 - 10/2020
3	Neutropenia 01/2021 - 04/2014
3	Inflammation (Inflammations) 12/2020 - 01/2018
3	WHIM syndrome 10/2019 - 04/2014
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 01/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2019
2	Hematologic Diseases (Blood Diseases) 01/2022 - 10/2021
2	COVID-19 11/2021 - 01/2021
2	Lymphopenia (Lymphocytopenia) 10/2021 - 01/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2018
2	monosomy Chromosome 7 01/2021 - 11/2020
2	Fibrosis (Cirrhosis) 12/2020 - 08/2011
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 07/2018
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2014 - 01/2011
2	Pancytopenia 07/2012 - 09/2011
2	Hyperplasia 04/2012 - 11/2008
2	Carcinogenesis 04/2012 - 01/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012 - 11/2008
2	Neoplasm Metastasis (Metastasis) 01/2011 - 02/2005
1	Iron Overload 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022
1	Macrocytic Anemia 10/2021
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021
1	Stroke (Strokes) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Osteomyelitis 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021

Drug/Important Bio-Agent (IBA)

7	eltrombopag FDA Link 01/2022 - 07/2012
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2005
7	EnzymesIBA 10/2021 - 01/2006
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2005
5	CytokinesIBA 01/2018 - 01/2006
4	GATA2 Transcription FactorIBA 01/2022 - 02/2014
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2011
4	ibrutinibIBA 01/2018 - 02/2015
3	purineIBA 12/2021 - 12/2013
3	Rituximab (Mabthera)FDA Link 12/2021 - 12/2013
3	Cladribine FDA LinkGeneric 12/2021 - 12/2013
3	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
3	carfilzomibIBA 11/2021 - 09/2015
3	Thrombopoietin (c-mpl Ligand)IBA 12/2020 - 07/2012
2	Decitabine FDA Link 01/2022 - 01/2021
2	Busulfan (Busulfex)FDA Link 01/2022 - 01/2018
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2021 - 01/2021
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2016
2	Thrombopoietin ReceptorsIBA 12/2020 - 01/2017
2	Reticulin (Reticular Fiber)IBA 12/2020 - 08/2011
2	AntigensIBA 11/2020 - 01/2018
2	Chimeric Antigen ReceptorsIBA 11/2020 - 01/2018
2	AutoantibodiesIBA 01/2020 - 08/2016
2	Agent OrangeIBA 01/2020 - 11/2015
2	plerixafor FDA Link 10/2019 - 04/2014
2	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 01/2016
2	Adenosine DeaminaseIBA 01/2016 - 03/2014
2	Chemokine ReceptorsIBA 02/2015 - 04/2014
2	Immunoglobulins (Immunoglobulin)IBA 04/2014 - 04/2014
2	Pharmaceutical PreparationsIBA 03/2014 - 04/2009
1	Messenger RNA (mRNA)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	pembrolizumabIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	ChromatinIBA 01/2022
1	IronIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2022
1	CohesinsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	NucleotidesIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	src-Family KinasesIBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2004
9	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2011
4	Transplantation 01/2022 - 09/2011
3	Cell Transplantation 01/2022 - 01/2021
2	Immunotherapy 11/2020 - 01/2018
1	Stem Cell Transplantation 01/2022